GGrantIndex
← Leaderboards

Shahin Lockman

Harvard University D/B/A Harvard School Of Public Health

$21,221,162
Attributed
$38,898,060
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.4M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$39,374,081 · 9

By mechanism

UM1$22,346,838 · 1
R01$12,251,164 · 4
D43$1,989,192 · 1
K24$1,685,995 · 1
K23$624,871 · 1
P20$476,021 · 1

Most similar at Harvard University D/B/A Harvard School Of Public Health

Same institution · by research overlap

Others in their field

Top investigators on “Botswana

Research focus

BotswanaAnti-Retroviral AgentsChildEpidemicClinical ResearchHiv InfectionsAdultPreventionResourcesEnrollmentAfricaMothersInfantResearch PersonnelPregnant WomenAreaAcquired Immunodeficiency SyndromeBasePublic Health SchoolsWomanProtocols DocumentationCohortProgramsClinical Trials

Grant awards (64)

Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU$2,111,151
UM1 · FY2025 · AI · contact PI
Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir Or Efavirenz$547,097
R01 · FY2025 · MH · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$302,400
D43 · FY2025 · TW
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART$179,083
K24 · FY2025 · AI · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$100,000
D43 · FY2025 · TW
Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU$1,898,133
UM1 · FY2024 · AI · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$202,400
D43 · FY2024 · TW
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART$177,782
K24 · FY2024 · AI · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$100,000
D43 · FY2024 · TW
Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU Y18 Supplement$79,898
UM1 · FY2024 · AI · contact PI
Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU$1,861,341
UM1 · FY2023 · AI · contact PI
Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir Or Efavirenz$592,042
R01 · FY2023 · MH · contact PI
Training in HIV Genomics, Treatment, and Cure Research in Botswana$304,400
D43 · FY2023 · TW
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART$188,668
K24 · FY2023 · AI · contact PI
Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir Or Efavirenz$51,196
R01 · FY2023 · MH · contact PI
Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU$1,932,439
UM1 · FY2022 · AI · contact PI
Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir Or Efavirenz$585,353
R01 · FY2022 · MH · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$300,640
D43 · FY2022 · TW
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART$194,012
K24 · FY2022 · AI · contact PI
Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU$1,941,572
UM1 · FY2021 · AI · contact PI
Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir Or Efavirenz$563,450
R01 · FY2021 · MH · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$300,640
D43 · FY2021 · TW
Addressing Major HIV Prevention and Health Outcomes Questions in an Era of Universal ART: Mentoring in a Community-Randomized Trial$188,938
K24 · FY2021 · AI · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$78,072
D43 · FY2021 · TW
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU$2,310,807
UM1 · FY2020 · AI · contact PI
Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir Or Efavirenz$595,812
R01 · FY2020 · MH · contact PI
Training in HIV/AIDS Prevention and Treatment Research in Botswana$300,640
D43 · FY2020 · TW
Addressing Major HIV Prevention and Health Outcomes Questions in an Era of Universal ART: Mentoring in a Community-Randomized Trial$188,938
K24 · FY2020 · AI · contact PI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU$2,702,555
UM1 · FY2019 · AI · contact PI
Addressing Major HIV Prevention and Health Outcomes Questions in an Era of Universal ART: Mentoring in a Community-Randomized Trial$188,858
K24 · FY2019 · AI · contact PI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU$1,570,005
UM1 · FY2018 · AI
Addressing Major HIV Prevention and Health Outcomes Questions in an Era of Universal ART: Mentoring in a Community-Randomized Trial$188,858
K24 · FY2018 · AI · contact PI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU$1,122,839
UM1 · FY2017 · AI
Planning for NCDs Research Center of Excellence in Southern Africa$236,966
P20 · FY2017 · CA
Addressing Major HIV Prevention and Health Outcomes Questions in an Era of Universal ART: Mentoring in a Community-Randomized Trial$190,858
K24 · FY2017 · AI · contact PI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU$1,198,312
UM1 · FY2016 · AI
Planning for NCDs Research Center of Excellence in Southern Africa$239,055
P20 · FY2016 · CA
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU$1,235,184
UM1 · FY2015 · AI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$348,090
R01 · FY2015 · HD
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU$2,382,602
UM1 · FY2014 · AI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$688,133
R01 · FY2014 · HD
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$885,020
R01 · FY2013 · HD
Effects of HIV and ARV Exposure on Child Health and Neurodevelopment in Botswana.$469,326
R01 · FY2013 · MH · contact PI
Effects of HIV and ARV Exposure on Child Health and Neurodevelopment in Botswana.$292,780
R01 · FY2013 · MH · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$1,009,257
R01 · FY2012 · HD
Effects of HIV and ARV Exposure on Child Health and Neurodevelopment in Botswana.$488,370
R01 · FY2012 · MH · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$938,095
R01 · FY2011 · HD
Effects of HIV and ARV Exposure on Child Health and Neurodevelopment in Botswana.$503,406
R01 · FY2011 · MH · contact PI
Effects of HIV and ARV Exposure on Child Health and Neurodevelopment in Botswana.$522,118
R01 · FY2010 · MH · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$513,609
R01 · FY2010 · HD
Maternal and Infant Health and HAART Outcomes in the Mashi PMTCT Study, Botswana$419,233
R01 · FY2010 · HD · contact PI
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana$131,499
R01 · FY2010 · HD
Effects of HIV and ARV Exposure on Child Health and Neurodevelopment in Botswana.$630,050
R01 · FY2009 · MH · contact PI
Maternal and Infant Health and HAART Outcomes in the Mashi PMTCT Study, Botswana$213,470
R01 · FY2009 · HD · contact PI
Health of HIV-Infected Mothers after pMTCT, Botswana$249,154
R01 · FY2007 · HD · contact PI
Health of HIV-Infected Mothers after pMTCT, Botswana$249,154
R01 · FY2006 · HD · contact PI
Health of HIV-Infected Mothers after pMTCT, Botswana$255,150
R01 · FY2005 · HD
Health of HIV-Infected Mothers after pMTCT, Botswana$255,150
R01 · FY2004 · HD
RESPIRATORY DISEASES/BSI STUDY$125,299
K23 · FY2004 · HD
Health of HIV-Infected Mothers after pMTCT, Botswana$255,150
R01 · FY2003 · HD
RESPIRATORY DISEASES/BSI STUDY$124,334
K23 · FY2003 · HD
RESPIRATORY DISEASES/BSI STUDY$123,406
K23 · FY2002 · HD
RESPIRATORY DISEASES/BSI STUDY$126,175
K23 · FY2001 · HD
RESPIRATORY DISEASES/BSI STUDY$125,657
K23 · FY2000 · HD